EE200300570A - Imidasotriasinoonide derivaadid ja nende kasutamine põletikuliste protsesside ja/või immuunhaigustevastu - Google Patents

Imidasotriasinoonide derivaadid ja nende kasutamine põletikuliste protsesside ja/või immuunhaigustevastu

Info

Publication number
EE200300570A
EE200300570A EEP200300570A EEP200300570A EE200300570A EE 200300570 A EE200300570 A EE 200300570A EE P200300570 A EEP200300570 A EE P200300570A EE P200300570 A EEP200300570 A EE P200300570A EE 200300570 A EE200300570 A EE 200300570A
Authority
EE
Estonia
Prior art keywords
imidazotriazinones
derivatives
inflammatory processes
immune diseases
use against
Prior art date
Application number
EEP200300570A
Other languages
English (en)
Estonian (et)
Inventor
Alonso-Alija Cristina
Gielen Heike
Hendrix Martin
Niew�hner Ulrich (surnud)
Schauss Dagmar
Bischoff Hilmar
Burkhardt Nils
Geiss Volker
Schlemmer Karl-Heinz
J. Cuthbert Nigel
Fitzgerald Mary
Sturton Graham
Original Assignee
Bayer Healthcare Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Healthcare Ag filed Critical Bayer Healthcare Ag
Publication of EE200300570A publication Critical patent/EE200300570A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D253/00Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
    • C07D253/02Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
    • C07D253/061,2,4-Triazines
    • C07D253/0651,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members
    • C07D253/071,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members with hetero atoms, or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
EEP200300570A 2001-06-01 2002-05-17 Imidasotriasinoonide derivaadid ja nende kasutamine põletikuliste protsesside ja/või immuunhaigustevastu EE200300570A (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0113344.6A GB0113344D0 (en) 2001-06-01 2001-06-01 Novel heterocycles 3
PCT/EP2002/005436 WO2002098879A1 (en) 2001-06-01 2002-05-17 Imidazotriazinones derivatives and their use against inflammatory processes and/or immune diseases

Publications (1)

Publication Number Publication Date
EE200300570A true EE200300570A (et) 2004-04-15

Family

ID=9915717

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200300570A EE200300570A (et) 2001-06-01 2002-05-17 Imidasotriasinoonide derivaadid ja nende kasutamine põletikuliste protsesside ja/või immuunhaigustevastu

Country Status (28)

Country Link
US (2) US7115602B2 (xx)
EP (1) EP1399447A1 (xx)
JP (1) JP2004536078A (xx)
KR (1) KR20040023605A (xx)
CN (1) CN1512993A (xx)
BG (1) BG108381A (xx)
BR (1) BR0210910A (xx)
CA (1) CA2449095A1 (xx)
CO (1) CO5540381A2 (xx)
CZ (1) CZ295609B6 (xx)
EC (1) ECSP034872A (xx)
EE (1) EE200300570A (xx)
GB (1) GB0113344D0 (xx)
GT (1) GT200200099A (xx)
HR (1) HRP20031090A2 (xx)
HU (1) HUP0400773A3 (xx)
MX (1) MXPA03010985A (xx)
NO (1) NO20035324D0 (xx)
NZ (1) NZ529848A (xx)
PE (1) PE20030231A1 (xx)
PL (1) PL366906A1 (xx)
RU (1) RU2003138078A (xx)
SK (1) SK14672003A3 (xx)
SV (1) SV2003001061A (xx)
UA (1) UA75149C2 (xx)
UY (1) UY27312A1 (xx)
WO (1) WO2002098879A1 (xx)
ZA (1) ZA200309111B (xx)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2388111A (en) * 2002-05-01 2003-11-05 Bayer Ag Novel imidazotriazinone compounds
GB2388594A (en) * 2002-05-16 2003-11-19 Bayer Ag Imidazo-triazine PDE 4 inhibitors
FR2850653A1 (fr) * 2003-02-04 2004-08-06 Univ Pasteur Derives de pyrazolotriazine, procede de preparation et utilisations
JP2006219374A (ja) 2003-06-13 2006-08-24 Daiichi Asubio Pharma Co Ltd Pde7阻害作用を有するイミダゾトリアジノン誘導体
TW200745106A (en) * 2005-10-03 2007-12-16 Astrazeneca Ab Chemical compounds
EP2685983B1 (en) 2011-03-17 2016-05-18 Algiax Pharmaceuticals GmbH Novel use of imidazotriazinones
WO2013156231A1 (en) * 2012-04-16 2013-10-24 Algiax Pharmaceuticals Gmbh Use of imidazotriazinones in neuropathic pain
US20170119775A1 (en) * 2014-03-28 2017-05-04 Algiax Pharmaceuticals Gmbh Treatment of cognitive disorders

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE791025A (fr) 1971-11-19 1973-05-07 Allen & Hanburys Ltd Composes heterocycliques
GB1457873A (en) 1973-01-04 1976-12-08 Allen & Hanburys Ltd Imidazotriazines
DK109578A (da) * 1977-03-25 1978-09-26 Allen & Hanburys Ltd Fremgangsmaade til fremstilling af heterocycliske forbindelser
GB2346877B (en) 1997-11-12 2001-12-05 Bayer Ag 2-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors
DE19827640A1 (de) * 1998-06-20 1999-12-23 Bayer Ag 7-Alkyl- und Cycloalkyl-substituierte Imidazotriazinone
US6503908B1 (en) * 1999-10-11 2003-01-07 Pfizer Inc Pharmaceutically active compounds

Also Published As

Publication number Publication date
PL366906A1 (en) 2005-02-07
CZ20033275A3 (en) 2004-03-17
US20050065153A1 (en) 2005-03-24
CA2449095A1 (en) 2002-12-12
SK14672003A3 (sk) 2004-08-03
ECSP034872A (es) 2004-01-28
BR0210910A (pt) 2004-06-08
US20030139415A1 (en) 2003-07-24
BG108381A (bg) 2004-11-30
NO20035324L (no) 2003-11-28
SV2003001061A (es) 2003-03-18
WO2002098879A1 (en) 2002-12-12
HRP20031090A2 (en) 2005-08-31
NO20035324D0 (no) 2003-11-28
KR20040023605A (ko) 2004-03-18
MXPA03010985A (es) 2004-10-28
HUP0400773A3 (en) 2007-09-28
ZA200309111B (en) 2004-11-24
NZ529848A (en) 2006-02-24
CN1512993A (zh) 2004-07-14
HUP0400773A2 (hu) 2004-07-28
UA75149C2 (en) 2006-03-15
CZ295609B6 (cs) 2005-08-17
JP2004536078A (ja) 2004-12-02
RU2003138078A (ru) 2005-05-27
CO5540381A2 (es) 2005-07-29
GT200200099A (es) 2003-02-13
EP1399447A1 (en) 2004-03-24
GB0113344D0 (en) 2001-07-25
US7115602B2 (en) 2006-10-03
UY27312A1 (es) 2003-02-28
PE20030231A1 (es) 2003-05-16

Similar Documents

Publication Publication Date Title
NL350076I1 (nl) Combinatie van thiencarbazone-methyl en foramsulfuron
NO20031442D0 (no) Morfolin-acetamidderivater for behandling av inflammatoriske sykdommer
NO20041272L (no) Tetracycline derivatives and methods of use thereof
NO20051493D0 (no) Imidazolpyridiner og fremgangsmater for fremstilling og anvendelse av de samme
EE200300485A (et) Tiohüdantoinid ja nende kasutamine diabeedi raviks
EE200300359A (et) Asendatud asaindooloksoatseetpiperasiini derivaatide koostis ja viirusevastane toime
NO20041975D0 (no) Bicyklisk oksopyridin og oksopyrimidinderivater
NO20044916L (no) Preparater av sulfinylacetamid
NO20033854D0 (no) N-but-3-enyl-norbuprenorfin og fremgangsmåter for anvendelse
IS6966A (is) Cýanó-tengd díhýdrópýrimídín efnasambönd og notkun þeirra við meðhöndlun sjúkdóma
FI20011671A0 (fi) Tuumorispesifiset oligosakkaridisekvenssit ja niiden käyttö
IS6967A (is) Ný cýanó-tengd díhýdrópýrimídín efnasambönd og notkun þeirra við meðhöndlun sjúkdóma
NO20040726L (no) Kombinasjonspreparater av arylsubstituerte propanolaminderivater med andre aktive forbindelser og anvendelse derav.
NO20041968L (no) Anvendelse av cystationin
EE200300328A (et) IL-18 inhibiitorite kasutamine südamehaiguse raviks ja/või ennetamiseks
EE200300570A (et) Imidasotriasinoonide derivaadid ja nende kasutamine põletikuliste protsesside ja/või immuunhaigustevastu
NO20023678L (no) Behandling av allergiske og inflammatoriske tilstander
NO20054346D0 (no) Sammensetninger og fremgangsmater for forebygging og behandling av endotoksinrelaterte sykdommer og tilstander
EE200400074A (et) Koostised ning nende kasutamine proliferatiivsetehaiguste raviks
NO20023737L (no) Fremgangsmåte og preparater for behandling av en inflammatorisk lidelse
EE200300454A (et) Bitsüklilised guanidiini derivaadid ja nende terapeutiline kasutamine
PT1381620E (pt) Dissacaridos hipersulfatados e metodos de utilizacao dos mesmos para o tratamento de inflamacoes
PT1392670E (pt) Derivados substituidos de c-furan-2-il-metilamina e c-tiofen-2-il-metilamina
DE60212388D1 (de) 2-heteroaryl-imidazotriazinone und ihre verwendung bei der behandlung von entzündungs- oder immunerkrankungen
EE200300466A (et) Püridoindolooni derivaatide kasutamine ravimite valmistamiseks